Literature DB >> 28420261

Added Value of Early Literacy Screening in Preschool Children.

Sai Nandini Iyer1, M Zachary Dawson2, Mark I Sawyer3, Neelab Abdullah4, Leya Saju4, Robert D Needlman4.   

Abstract

The Early Literacy Screener (ELS) is a brief screen for emergent literacy delays in 4- and 5-year-olds. Standard developmental screens may also flag these children. What is the value of adding the ELS? Parents of children aged 4 (n = 45) and 5 (n = 26) years completed the Ages and Stages Questionnaire-3 (ASQ-3), the Survey of Well-Being in Young Children (SWYC), and the ELS. Rates of positive agreement (PA), negative agreement (NA), and overall agreement (Cohen's κ) across the various screening tools were calculated. Early literacy delays were detected in 51% of those who passed the ASQ and 38% of those who passed the SWYC. For ELS versus ASQ, κ = 0.18, PA = 0.36 (95% CI = 0.23-0.51), and NA = 0.83 (95% CI = 0.66-0.92). For ELS versus SWYC, κ = 0.42, PA = 0.61 (95% CI = 0.45-0.75), and NA = 0.82 (95% CI = 0.65-0.92). The ELS adds value by flagging early literacy delays in many children who pass either the ASQ-3 or SWYC.

Entities:  

Keywords:  ASQ; SWYC; developmental screening; early literacy; preschool children; well-child care

Mesh:

Year:  2017        PMID: 28420261     DOI: 10.1177/0009922817702937

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

Review 1.  Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.

Authors:  Donna Perazzo; Ryan Moore; Nadine A Kasparian; Megan Rodts; Tzipi Horowitz-Kraus; Lori Crosby; Brian Turpin; Andrew F Beck; John Hutton
Journal:  Pediatr Res       Date:  2022-02-04       Impact factor: 3.953

2.  SCREENING FOR NEUROPSYCHOMOTOR AND SOCIAL-EMOTIONAL DEVELOPMENT IN CHILDREN UNDER 24 MONTHS OF AGE IN THE BRAZILIAN SEMI-ARID REGION.

Authors:  Artemizia Francisca de Sousa; Maísa de Lima Claro; Patrícia Helen Carvalho Rondó
Journal:  Rev Paul Pediatr       Date:  2021-05-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.